MyMD Pharmaceuticals (MYMD) Filings

8-K

MYMD MyMD Pharmaceuticals Inc

12 Apr 23

Regulation FD Disclosure

8:45am

4

Christopher C Chapman JR

5 Apr 23

MyMD Pharmaceuticals / Christopher C Chapman JR ownership change

4:28pm

8-K

MYMD MyMD Pharmaceuticals Inc

5 Apr 23

Departure of Directors or Certain Officers

4:25pm

8-K

MYMD MyMD Pharmaceuticals Inc

23 Mar 23

Departure of Directors or Certain Officers

4:30pm

DEFA14A

MYMD MyMD Pharmaceuticals Inc

22 Mar 23

Additional proxy soliciting materials

5:02pm

8-K

MYMD MyMD Pharmaceuticals Inc

22 Mar 23

Other Events

5:00pm

8-K

MYMD MyMD Pharmaceuticals Inc

20 Mar 23

MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis

9:15am

8-K

MYMD MyMD Pharmaceuticals Inc

8 Mar 23

MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls

8:40am

8-K

MYMD MyMD Pharmaceuticals Inc

2 Mar 23

MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines

8:45am

8-K

MYMD MyMD Pharmaceuticals Inc

28 Feb 23

Regulation FD Disclosure

4:15pm

8-K

MYMD MyMD Pharmaceuticals Inc

23 Feb 23

Entry into a Material Definitive Agreement

3:24pm

424B5

MYMD MyMD Pharmaceuticals Inc

23 Feb 23

Prospectus supplement for primary offering

9:00am

8-K

MYMD MyMD Pharmaceuticals Inc

21 Feb 23

MyMD Announces $15 Million Offering with Existing Investors

9:00am

SC 13G/A

Iroquois Capital Management, LLC

14 Feb 23

MyMD Pharmaceuticals / Iroquois Capital Management ownership change

7:40am

8-K

MYMD MyMD Pharmaceuticals Inc

3 Feb 23

Departure of Directors or Certain Officers

4:15pm

8-K

MYMD MyMD Pharmaceuticals Inc

14 Dec 22

Submission of Matters to a Vote of Security Holders

5:00pm